Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters
BioNTech SE's (NASDAQ: BNTX) CEO Ugur Sahin says the company, along with its partner Pfizer Inc (NYSE: PFE), could have data from trials…
Moderna’s Flagship Venture Firm Cashed $1.4B From Stock Sale In Two Months: Forbes
Almost a decade ago, Flagship Pioneering, a VC fund run and majority-owned by Moderna Inc’s (NASDAQ: MRNA) chairman and co-founder, Noubar…
70 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ:GNPX) shares surged 64.4% to close at $1.89 on Wednesday after climbing 219.44% on Tuesday.…
46 Stocks Moving In Wednesday’s Mid-Day Session
Gainers Neurotrope, Inc. (NASDAQ:NTRP) shares jumped 114.5% to $3.11 after the company announced it was awarded $2.7 million…
Moderna In Statement Says Its mRNA Vaccine Technology Could ‘ serve as a rapid and flexible platform that may be useful in responding to newly emerging viral threats, such as the novel coronavirus’; Says Working On Potential Vaccine Response To Emergen…
On the evening of January21, 2020, Moderna, Inc. provided a statement to a news outlet regarding its participation…